[1] PEIXOTO T S, GOMES M C, CASTRO GOMES D Q, et al. Analysis of survival rates and prognostic factors among patients with oral squamous cell carcinoma[J]. J Public Health-Heidelberg, 2017, 25(4):433-441. [2] NARUSE T, YANAMOTO S, MATSUSHITA Y, et al. Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer:An investigation of distant metastasis[J]. Mol Clin Oncol, 2016, 5(2):246-252. [3] CHIU K C, LEE C H, LIU S Y, et al. Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma[J]. Oral Oncol, 2015, 51(7):683-689. [4] JIN Z C, SHEN C F, ZHANG H D, et al. Chinese medicine Xiaoshui decoction inhibits malignant pleural effusion in mice and mediates tumor-associated macrophage polarization by activating autophagy[J]. J Ethnopharmacol, 2020, 249:112412. [5] KOWAL J, KORNETE M, JOYCE J A. Re-education of macrophages as a therapeutic strategy in cancer[J]. Immunotherapy, 2019, 11(8):677-689. [6] ZHANG Q, QIAO H W, WU D D, et al. Curcumin potentiates the galbanic acid-induced anti-tumor effect in non-small cell lung cancer cells through inhibiting Akt/mTOR signaling pathway[J]. Life Sci, 2019, 239:117044. [7] ZHEN L, FAN D S, YI X H, et al. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways[J]. Int J Clin Exp Pathol, 2014, 7(10):6438-6446. [8] LEE A Y, FAN C C, CHEN Y A, et al. Curcumin inhibits invasiveness and epithelial-mesenchymal transition in oral squamous cell carcinoma through reducing matrix metalloproteinase 2, 9 and modulating p53-E-cadherin pathway[J]. Integr Cancer Ther, 2015, 14(5):484-490. [9] CHIANG I T, LIU Y C, HSU F T, et al. Curcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-κB activity[J]. Oncol Rep, 2014, 31(4):1729-1737. [10] ZHOU Y Y, ZHANG T T, WANG X F, et al. Curcumin modulates macrophage polarization through the inhibition of the Ttoll-like receptor 4 expression and its signaling pathways[J]. Cell Physiol Biochem, 2015, 36(2):631-641. [11] VISHVAKARMA N K, KUMAR A, KUMAR A, et al. Myelopotentiating effect of curcumin in tumor-bearing host:Role of bone marrow resident macrophages[J]. Toxicol Appl Pharmacol, 2012, 263(1):111-121. [12] WU L L, TANG H L, ZHENG H, et al. Multiwalled carbon nanotubes prevent tumor metastasis through switching M2-polarized macrophages to M1 via TLR4 activation[J]. J Biomed Nanotechnol, 2019, 15(1):138-150. [13] YAO J J, DU Z H, LI Z B, et al. 6-Gingerol as an arginase inhibitor prevents urethane-induced lung carcinogenesis by reprogramming tumor supporting M2 macrophages to M1 phenotype+[J]. Food Funct, 2018, 9(9):4611-4620. [14] ZHANG Y, DU W, CHEN Z, et al. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma[J]. Exp Cell Res, 2017, 359(2):449-457. [15] KUANG D M, WU Y, CHEN N N, et al. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes[J]. Blood, 2007, 110(2):587-595. [16] KANEMARU H, YAMANE F, FUKUSHIMA K, et al. Antitumor effect of Batf2 through IL-12 p40 up-regulation in tumor-associated macrophages[J]. Proc Natl Acad Sci U S A, 2017, 114(35):E7331-E7340. [17] MULLINS D W, BURGER C J, ELGERT K D. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide[J]. J Immunol, 1999, 162(11):6811-6818. [18] LASEK W, ZAGOŻDŻON R, JAKOBISIAK M. Interleukin 12:still a promising candidate for tumor immunotherapy?[J]. Cancer Immunol Immunother, 2014, 63(5):419-435. [19] YAN T L, WANG M, XU Z, et al. Up-regulation of syncytin-1 contributes to TNF-α-enhanced fusion between OSCC and HUVECs partly via Wnt/β-catenin-dependent pathway[J]. Sci Rep, 2017, 7:40983. [20] HSING E W, SHIAH S G, PENG H Y, et al. TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility[J]. PLoS One, 2019, 14(3):e0213463. [21] VARGHESE S S, SUNIL P M, MADHAVAN R N. Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma:An immunohistochemical study[J]. Cancer Biomark, 2010, 8(3):155-160. [22] CUI C B, FU K W, YANG L, et al. Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway[J]. J Exp Clin Cancer Res, 2019, 38(1):229. [23] HAMIDULLAH, CHANGKIJA B, KONWAR R. Role of interleukin-10 in breast cancer[J]. Breast Cancer Res Treat, 2012, 133(1):11-21. [24] OGDEN C A, POUND J D, BATTH B K, et al. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages:implications for Burkitt's lymphoma[J]. J Immunol, 2005, 174(5):3015-3023. [25] MARTINENAITE E, MORTENSEN R E J, HANSEN M, et al. Frequent adaptive immune responses against arginase-1[J]. Oncoimmunology, 2018, 7(3):e1404215. [26] KUBOTA K, MORIYAMA M, FURUKAWA S, et al. CD163+ CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma[J]. Sci Rep, 2017, 7(1):1755. [27] KIM B, KIM E Y, LEE E J, et al. Panax notoginseng inhibits tumor growth through activating macrophage to M1 polarization[J]. Am J Chin Med, 2018, 46(6):1369-1385. [28] 陈亚利,欧阳军,孟晶茜,等.姜黄素对高尿酸血症大鼠肾组织中TGF-β1、NF-κB表达的影响[J].郑州大学学报(医学版),2018,53(3):360-364. [29] ZHANG J W, ZHENG Y L, LUO Y, et al. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/TLR4/NF-κB pathways in BV2 cells[J]. Mol Immunol, 2019, 116:29-37. |